← Back to Search

Text Messaging (Text+Step) for HIV/AIDS

N/A
Waitlist Available
Led By Cathy J Reback, PhD
Research Sponsored by Friends Research Institute, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights

Study Summary

This trial is testing whether sending texts or using a mobile-enhanced website can help reduce sexual risk behaviors and increase PrEP uptake among high-risk transgender youth and young adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Condomless Intercourse Events
Condomless Intercourse Events During Sex Work
Condomless Intercourse Events While High on Drugs/Alcohol
+2 more
Secondary outcome measures
Transgender Syndemic Health Index

Trial Design

3Treatment groups
Experimental Treatment
Group I: WebApp+StepExperimental Treatment1 Intervention
The TechStep WebApp+Step website intervention is a six-month technology-based intervention that uses peer-to-peer interaction, daily self-monitoring, and tailored content to address barriers to HIV sexual risk reduction and PrEP uptake and adherence.
Group II: Text+StepExperimental Treatment1 Intervention
The TechStep Text+Step messaging intervention is a six-month technology-based culturally competent theory-based text messaging intervention that sends three automated text messages to participants daily to reduce HIV risk and increase PrEP uptake and adherence.
Group III: InformationExperimental Treatment1 Intervention
The Information/No Step intervention includes nothing more than access to a website with information about trans health, HIV/STI information and local resources tailored for transgender persons.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Text Messaging (Text+Step)
2019
N/A
~260
WebApp (App+Step)
2019
N/A
~260
Information/No Step
2019
N/A
~260

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaOTHER
707 Previous Clinical Trials
8,581,037 Total Patients Enrolled
Emory UniversityOTHER
1,636 Previous Clinical Trials
2,560,376 Total Patients Enrolled
University of North CarolinaOTHER
166 Previous Clinical Trials
1,449,353 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

How old are they?
65+
What site did they apply to?
Baylor College of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
2019. "TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04000724.
~46 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top